Avantax Advisory Services Inc. Has $2.79 Million Stake in HCA Healthcare, Inc. (NYSE:HCA)

Avantax Advisory Services Inc. grew its position in HCA Healthcare, Inc. (NYSE:HCA) by 0.4% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 8,077 shares of the company’s stock after purchasing an additional 32 shares during the quarter. Avantax Advisory Services Inc.’s holdings in HCA Healthcare were worth $2,791,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Sanders Capital LLC grew its position in HCA Healthcare by 1.0% during the fourth quarter. Sanders Capital LLC now owns 11,655,563 shares of the company’s stock worth $3,498,417,000 after buying an additional 116,826 shares in the last quarter. Geode Capital Management LLC boosted its holdings in shares of HCA Healthcare by 1.3% in the 4th quarter. Geode Capital Management LLC now owns 3,871,057 shares of the company’s stock valued at $1,159,882,000 after purchasing an additional 50,321 shares in the last quarter. Capital World Investors lifted its stake in shares of HCA Healthcare by 0.7% in the 4th quarter. Capital World Investors now owns 2,928,452 shares of the company’s stock valued at $878,975,000 after acquiring an additional 19,121 shares during the last quarter. Northern Trust Corp lifted its stake in shares of HCA Healthcare by 12.4% in the 4th quarter. Northern Trust Corp now owns 2,017,971 shares of the company’s stock valued at $605,694,000 after acquiring an additional 223,248 shares during the last quarter. Finally, Nuveen Asset Management LLC lifted its stake in shares of HCA Healthcare by 4.5% in the 4th quarter. Nuveen Asset Management LLC now owns 1,865,771 shares of the company’s stock valued at $560,011,000 after acquiring an additional 81,105 shares during the last quarter. Institutional investors and hedge funds own 62.73% of the company’s stock.

Insider Buying and Selling

In other HCA Healthcare news, COO Jon M. Foster sold 15,698 shares of the business’s stock in a transaction on Tuesday, May 13th. The shares were sold at an average price of $369.32, for a total transaction of $5,797,585.36. Following the sale, the chief operating officer owned 12,646 shares of the company’s stock, valued at $4,670,420.72. The trade was a 55.38% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Insiders own 1.30% of the company’s stock.

Wall Street Analysts Forecast Growth

HCA has been the subject of several analyst reports. Wells Fargo & Company raised HCA Healthcare from an “underweight” rating to an “equal weight” rating and raised their target price for the stock from $320.00 to $385.00 in a research report on Thursday, May 29th. Guggenheim started coverage on HCA Healthcare in a report on Wednesday, April 9th. They set a “neutral” rating for the company. Morgan Stanley decreased their price target on HCA Healthcare from $410.00 to $400.00 and set an “equal weight” rating for the company in a report on Monday. Royal Bank Of Canada decreased their price target on HCA Healthcare from $404.00 to $401.00 and set an “outperform” rating for the company in a report on Monday. Finally, Truist Financial increased their price target on HCA Healthcare from $390.00 to $415.00 and gave the stock a “buy” rating in a report on Wednesday, July 16th. Nine analysts have rated the stock with a hold rating, nine have issued a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, HCA Healthcare has an average rating of “Moderate Buy” and a consensus price target of $396.46.

HCA Healthcare Price Performance

HCA stock opened at $344.52 on Wednesday. The company has a market capitalization of $82.88 billion, a P/E ratio of 14.48, a price-to-earnings-growth ratio of 1.14 and a beta of 1.47. The company has a debt-to-equity ratio of 69.07, a quick ratio of 0.86 and a current ratio of 0.98. HCA Healthcare, Inc. has a 52-week low of $289.98 and a 52-week high of $417.14. The business has a 50-day simple moving average of $372.05 and a two-hundred day simple moving average of $346.40.

HCA Healthcare (NYSE:HCA) last posted its earnings results on Friday, July 25th. The company reported $6.84 EPS for the quarter, topping the consensus estimate of $6.20 by $0.64. HCA Healthcare had a net margin of 8.21% and a negative return on equity of 7,363.11%. The firm had revenue of $18.61 billion for the quarter, compared to analysts’ expectations of $18.49 billion. During the same quarter last year, the firm earned $5.50 EPS. The company’s quarterly revenue was up 6.4% compared to the same quarter last year. Research analysts expect that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 30th. Investors of record on Tuesday, September 16th will be paid a $0.72 dividend. The ex-dividend date of this dividend is Tuesday, September 16th. This represents a $2.88 annualized dividend and a yield of 0.84%. HCA Healthcare’s payout ratio is 12.11%.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.